American Healthcare REIT COO reports RSU activity

Q: What did AHR COO Gabriel Willhite report in this Form 4?

Gabriel Willhite reported vesting of restricted stock units and a new RSU grant. Two RSU tranches converted into common shares, some shares were withheld for taxes, and he received an additional 10,317 time-based RSUs.

Q: How many American Healthcare REIT shares vested for Gabriel Willhite?

Two RSU tranches totaling 15,205 common shares vested and converted on March 25, 2026. These shares came from previously granted time-based RSUs that were scheduled to vest on that date under his compensation plan.

Q: How many AHR shares were withheld for Gabriel Willhite’s taxes?

The company withheld 4,948 and 2,790 common shares, in total 7,738 shares, at a price of $48.25 per share. These withholdings satisfied Gabriel Willhite’s tax obligations related to the vesting of his restricted stock units.

Q: What new RSUs did Gabriel Willhite receive from American Healthcare REIT?

Gabriel Willhite received a new grant of 10,317 time-based restricted stock units on March 25, 2026. These RSUs will vest in equal installments on March 10, 2027, 2028 and 2029, conditioned on his continued employment with the company.

American Healthcare REIT, Inc. Chief Operating Officer Gabriel M. Willhite reported routine equity compensation activity.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

American Healthcare REIT, Inc. Chief Operating Officer Gabriel M. Willhite reported routine equity compensation activity. On March 25, 2026, two blocks of time-based restricted stock units converted into a total of 15,205 shares of common stock as they vested. To cover associated tax obligations, 4,948 and 2,790 common shares were withheld by the company at a price of $48.25 per share. Following these transactions, Willhite directly held 145,051 shares of common stock. He also received a new grant of 10,317 time-based RSUs that will vest in equal installments on March 10, 2027, 2028 and 2029, subject to continued employment.

Insider Trade Summary

15,205 shares exercised/converted

Exercise 7 txns

Insider Willhite Gabriel M

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	9,723	$0.00	$0.00
Exercise	Restricted Stock Unit	5,482	$0.00	$0.00
Grant/Award	Restricted Stock Unit	10,317	$0.00	$0.00
Exercise	Common Stock	9,723	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	4,948	$48.25	$239K
Exercise	Common Stock	5,482	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,790	$48.25	$135K

Holdings After Transaction: Restricted Stock Unit — 31,006 contracts (Direct); Common Stock — 145,051 shares (Direct)

Footnotes (5)

F1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock.
F2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of time-based RSUs on March 25, 2026.
F3. On March 25, 2024, the Issuer awarded the Reporting Person 29,170 time-based RSUs. The RSUs vest ratably on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date).
F4. On March 25, 2025, the Issuer awarded the Reporting Person 16,447 time-based RSUs. The RSUs vest ratably on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date).
F5. On March 25, 2026, the Issuer awarded the Reporting Person 10,317 time-based RSUs. The RSUs will vest ratably on March 10, 2027, 2028 and 2029 (subject to continuous employment through each vesting date).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AHR COO Gabriel Willhite report in this Form 4?

Gabriel Willhite reported vesting of restricted stock units and a new RSU grant. Two RSU tranches converted into common shares, some shares were withheld for taxes, and he received an additional 10,317 time-based RSUs.

How many American Healthcare REIT shares vested for Gabriel Willhite?

Two RSU tranches totaling 15,205 common shares vested and converted on March 25, 2026. These shares came from previously granted time-based RSUs that were scheduled to vest on that date under his compensation plan.

How many AHR shares were withheld for Gabriel Willhite’s taxes?

The company withheld 4,948 and 2,790 common shares, in total 7,738 shares, at a price of $48.25 per share. These withholdings satisfied Gabriel Willhite’s tax obligations related to the vesting of his restricted stock units.

What is Gabriel Willhite’s shareholding in American Healthcare REIT after these transactions?

After the reported transactions, Gabriel Willhite directly held 145,051 shares of common stock. This figure reflects the vested shares from restricted stock units minus the shares withheld by the company to cover his associated tax obligations.

What new RSUs did Gabriel Willhite receive from American Healthcare REIT?

Gabriel Willhite received a new grant of 10,317 time-based restricted stock units on March 25, 2026. These RSUs will vest in equal installments on March 10, 2027, 2028 and 2029, conditioned on his continued employment with the company.

Were Gabriel Willhite’s AHR transactions open-market buys or sales?

No open-market buys or sales were reported. The Form 4 shows RSU vesting, related share issuances, and shares withheld for taxes, along with a new RSU grant, rather than discretionary purchases or sales in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/27/2026 - 04:32 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Willhite Gabriel M

(Last)

(First)

(Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE, STE 300

(Street)

IRVINE

CALIFORNIA

92612

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/25/2026		M		9,723	A	⁽¹⁾	147,307	D
Common Stock	03/25/2026		F		4,948⁽²⁾	D	$48.25	142,359	D
Common Stock	03/25/2026		M		5,482	A	⁽¹⁾	147,841	D
Common Stock	03/25/2026		F		2,790⁽²⁾	D	$48.25	145,051	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	03/25/2026		M			9,723	⁽³⁾	⁽³⁾	Common Stock	9,723	$0	9,724	D
Restricted Stock Unit	⁽¹⁾	03/25/2026		M			5,482	⁽⁴⁾	⁽⁴⁾	Common Stock	5,482	$0	10,965	D
Restricted Stock Unit	⁽¹⁾	03/25/2026		A		10,317		⁽⁵⁾	⁽⁵⁾	Common Stock	10,317	$0	10,317	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock.

2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of time-based RSUs on March 25, 2026.

3. On March 25, 2024, the Issuer awarded the Reporting Person 29,170 time-based RSUs. The RSUs vest ratably on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date).

4. On March 25, 2025, the Issuer awarded the Reporting Person 16,447 time-based RSUs. The RSUs vest ratably on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date).

5. On March 25, 2026, the Issuer awarded the Reporting Person 10,317 time-based RSUs. The RSUs will vest ratably on March 10, 2027, 2028 and 2029 (subject to continuous employment through each vesting date).

	/s/ GABRIEL M. WILLHITE	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR